Evidence map›Paper›PMID 39963473›Full record

ArticleACG case reports journal2025

A Post-transplant Immunosuppression Complication: Epstein-Barr Virus-Positive Classic Hodgkin Lymphoma Post-transplant Lymphoproliferative Disorder.

Himesh B Zaver, Gautham Prakash, Samuel Plant, Jigisha Chaudhari, Jason Erno, Ayman Mithqal, Elizabeth Courville, Enrica Marchi, Zachary Henry

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in ACG case reports journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Himesh B ZaverDivision of Gastroenterology and Hepatology, Department of Medicine, University of Virginia, Charlottesville, VA.
Gautham PrakashDivision of Hematology and Oncology, Department of Medicine, University of Virginia, Charlottesville, VA.
Samuel PlantDivision of Body Imaging, Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA.
Jigisha ChaudhariDivision of Anatomic Pathology, Department of Pathology, University of Virginia, Charlottesville, VA.
Jason ErnoDivision of General, Geriatric, Palliative & Hospital Medicine, Department of Medicine, University of Virginia, Charlottesville, VA.
Ayman MithqalDivision of Body Imaging, Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA.
Elizabeth CourvilleDivision of Anatomic Pathology, Department of Pathology, University of Virginia, Charlottesville, VA.
Enrica MarchiDivision of Hematology and Oncology, Department of Medicine, University of Virginia, Charlottesville, VA.
Zachary HenryDivision of Gastroenterology and Hepatology, Department of Medicine, University of Virginia, Charlottesville, VA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-transplant lymphoproliferative disorder (PTLD) is a potential life-threatening complication after solid organ transplantation. PTLD can be associated with Epstein-Barr virus through either primary infection or reactivation during treatment with immunosuppressive medications. We present a rare case of Epstein-Barr virus-positive classical Hodgkin lymphoma PTLD following liver transplantation, which was initially misattributed to late transplant rejection and raised concerns for cholangiocarcinoma due to abnormal laboratory and imaging findings.

Indexed as

Epstein-Barr virusorthotopic liver transplantationpost-transplant lymphoproliferative disorder

Identifiers

PMID39963473
PMCPMC11832203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.